Avanos Medical Inc (NYSE:AVNS)
$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Avanos Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 10:00PM GMT
Release Date Price: $32.59 (-1.18%)
Joseph F. Woody
Avanos Medical, Inc. - CEO & Director

Thank you. Good afternoon. I'm Joe Woody. I'm the CEO of Avanos, and I thank you for your interest in Avanos.

Before we get started, I just want to share with everyone how excited I am that Michael Greiner has joined us as our Chief Financial Officer. He comes to us from AngioDynamics. He has over 20 years of experience in executive financial management, and he's going to be a critical part of us advancing our growth, expanding our margin, and importantly, he'll have the IT organization reporting directly into him.

I imagine that he is listening right now back in Alpharetta. He did not make the trip with us because he is, in fact, going to be studying up and immersing himself in the business. He will be joining us on the earnings call in the last week of February, and he'll be out at Raymond James as well as at Barclays in Miami. And from there, he'll be on the circuit. So we welcome him aboard.

Today, I'm going to talk about the strategy of the business. We'll talk about where we are with the transformation of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot